Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Gelatinases, belonging to the matrix metalloproteases, contribute to tissue destruction in inflammatory demyelinating disorders of the central nervous system such as multiple sclerosis. We used experimental autoimmune encephalomyelitis (EAE) as an animal model to evaluate the effect of a hydroxamate matrix metalloprotease inhibitor (GM 6001) on inflammatory demyelination. A single dose of the inhibitor, given intraperitoneally, provided sufficient levels in the cerebrospinal fluid of animals with EAE to induce at least a partial inhibition of the gelatinase activity in the cerebrospinal fluid. When administered daily either from the time of disease induction or from the onset of clinical signs, GM 6001 suppressed the development or reversed clinical EAE in a dose-dependent way, respectively. Animals returned to the same clinical course as the nontreated group after cessation of treatment. Animals treated from the onset of clinical signs had normal permeability of the blood-brain barrier, compared with the enhanced permeability in nontreated animals. These results indicate that matrix metalloprotease inhibition can reverse ongoing EAE. This effect appears to be mediated mainly through restoration of the damaged blood-brain barrier in the inflammatory phase of the disease, since, the degree of demyelination and inflammation did not differ between the treatment groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural biochemistry and activation of matrix metalloproteases
Kleiner, D. E., & Stetler-Stevenson, W. G. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90040-w · Cited by 342
Gijbels, K., Masure, S., Carton, H., & Opdenakker, G. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90192-n · Cited by 281
Self-citationTIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
Rosenberg, G. A., Kornfeld, M., Estrada, E., Kelley, R. O., Liotta, L. A., & Stetler-Stevenson, W. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90681-x · Cited by 281
Grobelny, D., Poncz, L., & Galardy, R. E. (1992) · Biochemistry · doi:10.1021/bi00146a017 · Cited by 273
Self-citationYOUL, B. D., TURANO, G., MILLER, D. H., TOWELL, A. D., MACMANUS, D. G., MOORE, S. G., JONES, S. J., BARRETT, G., KENDALL, B. E., MOSELEY, I. F., et al. (1991) · Brain · doi:10.1093/brain/114.6.2437 · Cited by 259
The Role of Plasmhogen Activators in the Regulation of Connective Tissue Metalloproteinasesa
MURPHY, G., ATKINSON, S., WARD, R., GAVRILOVIC, J., & REYNOLDS, J. J. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb51590.x · Cited by 245
The pathological evolution of multiple sclerosis
McDonald, W. I., MILLER, D. H., & Barnes, D. (1992) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1992.tb00794.x · Cited by 196
Gijbels, K., Proost, P., Masure, S., Carton, H., Billiau, A., & Opdenakker, G. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490360409 · Cited by 191
Self-citationGijbels, K., van Damme, J., Proost, P., Put, W., Carton, H., & Billiau, A. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200134 · Cited by 148
Self-citationStudies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen.
Mackay, A. R., Hartzler, J. L., Pelina, M. D., & Thorgeirsson, U. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45827-9 · Cited by 113
Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis
Brosnan, C. F., Cammer, W., Norton, W. T., & Bloom, B. R. (1980) · Nature · doi:10.1038/285235a0 · Cited by 112
Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases.
Schultz, G. S., Strelow, S., Stern, G. A., Chegini, N., Grant, M. B., Galardy, R. E., Grobelny, D. W., Rowsey, J. J., Stonecipher, K. G., & Parmley, V. C. (1992) · PubMed · Cited by 111
Self-citationPathology of Multiple Sclerosis
Kipp, M., van der Valk, P., & Amor, S. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712801661248 · Cited by 95
Steinman, L. (1993) · Scientific American · doi:10.1038/scientificamerican0993-106 · Cited by 88
Self-citationFarrell, C. L., Stewart, P. A., & Maestro, R. F. D. (1987) · Journal of Neuro-Oncology · doi:10.1007/bf00195612 · Cited by 87
Steinman, L. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60779-8 · Cited by 58
Self-citationPathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes.
Banik, N. L. (1992) · PubMed · Cited by 58
Smith, M. E., & Amaducci, L. A. (1982) · Neurochemical Research · doi:10.1007/bf00965121 · Cited by 38
Pathophysiology of Demyelinationa
Rasminsky, M. (1984) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1984.tb14776.x · Cited by 27
Inuzuka, T., Sato, S., Baba, H., & Miyatake, T. (1988) · Neurochemical Research · doi:10.1007/bf00971537 · Cited by 8
Cited by
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
Virág, L., & Szabó, C. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.375 · Cited by 1,373
Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)
Van den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (2002) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230290771546 · Cited by 946
Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System
Steinman, M. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81107-1 · Cited by 903
Matrix metalloproteinases in neuroinflammation
Rosenberg, G. A. (2002) · Glia · doi:10.1002/glia.10108 · Cited by 868
Metadata
- Authors
- Gijbels, K., Galardy, R. E., & Steinman, L.
- Venue
- Journal of Clinical Investigation
- Published
- 1994-12-01
- Volume
- 94
- Issue
- 6
- Pages
- 2177-2182
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2041533977
- Cited by
- 339
- References
- 20
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.